Background: The effectiveness of tumor markers in evaluating outcomes of patients with
hepatocellular carcinoma (HCC) remains to be clarified. Summary: The usefulness of the HCC …

… are provided for novel research approaches, which may contribute to the final target: to
cure more patients with hepatocellular carcinoma and with an improved long term outcome. …

Purpose: Validated biomarkers of prognosis and response to drug have not been identified
for patients with hepatocellular carcinoma (HCC). One of the objectives of the phase III, …

… outcome of patients with hepatocellular carcinoma (HCC) in non-cirrhotic liver depending
on the mode of primary treatment and to define clinicopathological factors influencing patients' …

BACKGROUND: The prognostic significance of p53 aberration in hepatocellular carcinoma (HCC)
remains inconclusive. This systematic review and meta-analysis aimed to provide …

… surgical outcomes; therefore, it should be recognized that early hepatocellular carcinoma is
a … The aim of this study is to clarify the characteristics and surgical outcomes of patients with …

… of hepatocellular carcinoma (HCC). However, little has been documented in the literature
regarding the outcomes of HCC patients … , and outcomes of this specific group of patients. …

… Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the second
most common cause of cancer-related death 1. As it is frequently associated with chronic …

Introduction This is a case-matched analysis of patients undergoing laparoscopic versus
open hepatectomy for hepatocellular carcinoma (HCC), with specific regard to margin status …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading
cause of cancer‐related deaths worldwide. Sarcomatoid HCC is a rare histological subtype of …